NCT01410383View on ClinicalTrials.gov

Efficacy and Safety Study of Eprotirome in HeFH Patients Who Are on Optimal Standard of Care

PHASE3TerminatedINTERVENTIONAL

Enrollment

236

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2014

Conditions

Heterozygous Familial Hypercholesterolaemia

Interventions

DRUG

Placebo

Tablets taken daily

DRUG

Eprotirome

Tablets taken daily

DRUG

Eprotirome

Tablets taken daily

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Karo Bio AB

INDUSTRY